This brand name is authorized in Hong Kong, New Zealand, Singapore, Turkey, United States
The drug M-M-R II contains a combination of these active pharmaceutical ingredients (APIs):
| 1 Measles, live attenuated |
|
|
| 2 Mumps, live attenuated |
|
|
|
3
Rubella, live attenuated
UNII U751HEX436 - RUBELLA VIRUS
|
|
Rubella virus vaccine contains live attenuated rubella virus, produced in human diploid (MRC-5) cells. It is a virus vaccine for active immunization against rubella that is subcutaneously administered. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BD52 | Measles, combinations with mumps and rubella, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BD Measles vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 64166 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 1482 |
| Country: SG | Health Sciences Authority | Identifier(s): 02056P |
| Country: TR | ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu | Identifier(s): 8699636960202 |
| Country: US | FDA, National Drug Code | Identifier(s): 0006-4681, 50090-1860 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
